Improving breeding to combat Amoebic Gill Disease in Salmon

Published on Feb. 1, 2018

Improving breeding to combat Amoebic Gill Disease in Salmon

Hendrix Genetics, along with its partners, work to use animal breeding to combat AGD in salmon.

Aquaculture, specifically related to farmed salmon is rapidly growing. This is fuelled in part  by the need to protect the world’s supply of wild fish. Better breeding methods and new technology have also helped it become more efficient and sustainable with every passing year. There are still challenges in the industry and like in any kind of animal agriculture, disease is always a potential threat. In salmon aquaculture, one of the greatest challenges faced by the industry is Amoebic Gill Disease (AGD). This disease is caused by the amoeba Neoparamoeba perurans, and whilst it targets almost every species of farmed fish, it has been a particular problem in salmon production. AGD  costs the industry millions of dollars a year in treatment and lost productivity. Aside from being a serious economic issue, it also has a large impact on the animal welfare of farmed salmon. 

R&D (17).jpg

This research allows us to improve not just production, but also animal welfare and sustainability in the industry.

R&D (17).jpg
Alastair Hamilton
Head of Molecular Biology, Aquaculture

The solution

Hendrix Genetics geneticist Dr. Alastair Hamilton knows first-hand the power of better breeding to tackle diseases. Together with The Roslin Institute in Edinburgh, he led research on possible solutions through breeding. They found that resistance to AGD is a heritable trait and therefore a candidate for selective breeding. Our research further demonstrated that resistance to AGD is strongly linked to two regions on chromosome 18. This makes the trait a good candidate for genomic selection. Early results in our breeding program suggest that genomic selection was 18% more effective in improving resistance to AGD than traditional selection ignoring DNA information. Moreover, this was achieved using as few as 1000 SNPs (represents a difference in a single DNA building block) a tiny number by industry standards, suggesting selection could be highly efficient and cost effective.

WCGALP 11

Related articles

, by
Latest CSR report highlights examples of progress in sustainability

We are very pleased to publish our second Corporate Social Responsibility (CSR) report. This report gives a detailed overview of our efforts in sustainability and the ways in which we are making a po…

Hendrix Genetics welcomes Pelayo Casanovas as Managing Director for BU Layers

We are pleased to welcome Pelayo Casanovas to the position of Managing Director for Hendrix Genetics Layers.

, by
Delivering excellence "in China, for China"

Meet Managing Director for Business Unit China, Ji Chen, and learn more about Hendrix Genetics’ plan to deliver high performing products for this dynamic market.